Purdue’s Sacklers Consider Adding $1 Billion More to Opioid Settlement February 11, 2022 By Jef Feeley, Jeremy Hill and Malathi Nayak Members of the billionaire Sackler family that own Purdue Pharma LP are weighing whether to add $1 billion to the...
Why Jury’s Opioid Verdict Against Pharmacy Chains May Not Survive Appeal November 30, 2021 By Jef Feeley While a Cleveland jury concluded Walmart Inc., CVS Health Corp. and Walgreens Boots Alliance Inc. exacerbated Ohio’s opioid epidemic with...
Ohio Jury Finds Major Pharmacy Chains Fueled Opioid Crisis November 24, 2021 By Jef Feeley A Cleveland jury concluded Walmart Inc., CVS Health Corp. and Walgreens Boots Alliance Inc. helped create a public-health crisis by...
How J&J Shaped Report on Talc’s Links to Cancer November 9, 2021 By Jef Feeley and Anna Edney Unsealed emails reveal the role baby-powder maker Johnson & Johnson played in a report that an industry group submitted to...
Judge Dismisses Chemours Shareholder Suit Over DuPont Spinoff Liabilities November 3, 2021 By Jef Feeley and Michael Leonard A Delaware judge dismissed a suit by Chemours Co. shareholders alleging directors misled them about the company’s financial health and...
Months Before Bankruptcy Move, J&J Offered $4B to Settle Talcum Claims October 22, 2021 By Jef Feeley Months before putting one of its units into bankruptcy, Johnson & Johnson offered $4 billion to settle with victims of...
Potentially ‘Massive’ Litigation Over Recalled Philips Sleep Apnea Devices Advances October 12, 2021 By Jef Feeley Royal Philips NV will face more than 100 U.S. lawsuits gathered in a Pennsylvania court over its recall of more...
Drug Industry Faces First High-Stakes Opioid Jury Trial June 29, 2021 By Jef Feeley Jurors on New York’s Long Island are set to determine whether a group of opioid makers and drug distributors created...
J&J Reports $263M Resolution of N.Y. Opioid Lawsuits Before Trial June 28, 2021 By Jef Feeley Johnson & Johnson said it agreed to pay $263 million to resolve opioid lawsuits filed in New York, settling the...
Investor Suit Alleges Chemours Directors Misled About Firm’s Financials, Liabilities March 1, 2021 By Jef Feeley Chemours Co.’s directors were accused in a lawsuit of duping shareholders about its financial health and the extent of its...